243 related articles for article (PubMed ID: 24827113)
1. Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance.
Lee ZW; Teo XY; Tay EY; Tan CH; Hagen T; Moore PK; Deng LW
Br J Pharmacol; 2014 Sep; 171(18):4322-36. PubMed ID: 24827113
[TBL] [Abstract][Full Text] [Related]
2. The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo.
Lee ZW; Zhou J; Chen CS; Zhao Y; Tan CH; Li L; Moore PK; Deng LW
PLoS One; 2011; 6(6):e21077. PubMed ID: 21701688
[TBL] [Abstract][Full Text] [Related]
3. Sodium/calcium exchanger is involved in apoptosis induced by H
Szadvari I; Hudecova S; Chovancova B; Matuskova M; Cholujova D; Lencesova L; Valerian D; Ondrias K; Babula P; Krizanova O
Nitric Oxide; 2019 Jun; 87():1-9. PubMed ID: 30849492
[TBL] [Abstract][Full Text] [Related]
4. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
[TBL] [Abstract][Full Text] [Related]
5. H
Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
[TBL] [Abstract][Full Text] [Related]
6. Parenteral Na
Drapala A; Koszelewski D; Tomasova L; Ostaszewski R; Grman M; Ondrias K; Ufnal M
Acta Biochim Pol; 2017; 64(3):561-566. PubMed ID: 28753683
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide donors prevent lipopolysaccharide-induced airway hyperreactivity in an in vitro model of chronic inflammation in mice.
Karaman Y; Kaya-Yasar Y; Bozkurt TE; Sahin-Erdemli I
Basic Clin Pharmacol Toxicol; 2021 May; 128(5):652-660. PubMed ID: 33369105
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes.
Merighi S; Gessi S; Varani K; Fazzi D; Borea PA
Pharmacol Res; 2012 Nov; 66(5):428-36. PubMed ID: 22842066
[TBL] [Abstract][Full Text] [Related]
9. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
10. GYY4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the AMPK/mTOR signal pathway in H9c2 cells.
Wei WB; Hu X; Zhuang XD; Liao LZ; Li WD
Mol Cell Biochem; 2014 Apr; 389(1-2):249-56. PubMed ID: 24374752
[TBL] [Abstract][Full Text] [Related]
11. Intracellular Hyper-Acidification Potentiated by Hydrogen Sulfide Mediates Invasive and Therapy Resistant Cancer Cell Death.
Lee ZW; Teo XY; Song ZJ; Nin DS; Novera W; Choo BA; Dymock BW; Moore PK; Huang RY; Deng LW
Front Pharmacol; 2017; 8():763. PubMed ID: 29163155
[TBL] [Abstract][Full Text] [Related]
12. Exogenous hydrogen sulfide inhibits oral mucosal wound-induced macrophage activation via the NF-κB pathway.
Zhuang R; Guo L; Du J; Wang S; Li J; Liu Y
Oral Dis; 2018 Jul; 24(5):793-801. PubMed ID: 29383805
[TBL] [Abstract][Full Text] [Related]
13. Regulating ferroportin-1 and transferrin receptor-1 expression: A novel function of hydrogen sulfide.
Zhang MW; Yang G; Zhou YF; Qian C; Mu MD; Ke Y; Qian ZM
J Cell Physiol; 2019 Apr; 234(4):3158-3169. PubMed ID: 30370692
[TBL] [Abstract][Full Text] [Related]
14. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice.
Liu Z; Han Y; Li L; Lu H; Meng G; Li X; Shirhan M; Peh MT; Xie L; Zhou S; Wang X; Chen Q; Dai W; Tan CH; Pan S; Moore PK; Ji Y
Br J Pharmacol; 2013 Aug; 169(8):1795-809. PubMed ID: 23713790
[TBL] [Abstract][Full Text] [Related]
15. Slow sulfide donor GYY4137 potentiates effect of paclitaxel on colorectal carcinoma cells.
Kajsik M; Chovancova B; Liskova V; Babula P; Krizanova O
Eur J Pharmacol; 2022 May; 922():174875. PubMed ID: 35314158
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide effects on stomatal apertures.
Lisjak M; Teklić T; Wilson ID; Wood M; Whiteman M; Hancock JT
Plant Signal Behav; 2011 Oct; 6(10):1444-6. PubMed ID: 21904118
[TBL] [Abstract][Full Text] [Related]
17. H
Untereiner AA; Oláh G; Módis K; Hellmich MR; Szabo C
Biochem Pharmacol; 2017 Jul; 136():86-98. PubMed ID: 28404377
[TBL] [Abstract][Full Text] [Related]
18. A new slow releasing, H₂S generating compound, GYY4137 relaxes spontaneous and oxytocin-stimulated contractions of human and rat pregnant myometrium.
Robinson H; Wray S
PLoS One; 2012; 7(9):e46278. PubMed ID: 23029460
[TBL] [Abstract][Full Text] [Related]
19. Negative Effect of Ellagic Acid on Cytosolic pH Regulation and Glycolytic Flux in Human Endometrial Cancer Cells.
Abdelazeem KNM; Singh Y; Lang F; Salker MS
Cell Physiol Biochem; 2017; 41(6):2374-2382. PubMed ID: 28467979
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide impacts on inflammation-induced adipocyte dysfunction.
Comas F; Latorre J; Cussó O; Ortega F; Lluch A; Sabater M; Castells-Nobau A; Ricart W; Ribas X; Costas M; Fernández-Real JM; Moreno-Navarrete JM
Food Chem Toxicol; 2019 Sep; 131():110543. PubMed ID: 31154084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
